Christina (Tina) P./LinkedIn
Sep 13, 2026, 15:33
Christina (Tina) P.: Antiphospholipid Syndrome After Unprovoked VTE
Christina (Tina) P., CEO and Co-Founder of APS Foundation of America, shared on LinkedIn:
”Prevalence and outcomes of antiphospholipid syndrome after unprovoked venous thromboembolism: a multicenter real-world data analysis.
Guidance for antiphospholipid antibody.”
Stay updated with Hemostasis Today.
-
Oct 28, 2026, 13:27M. Alejandro Mosso-Pani: Dengue in Florida – Why Platelet Function Matters
-
Oct 28, 2026, 13:13Michael Cahillane: Three-Buffy-Coat Platelets – Strengthening Blood Supply Resilience
-
Oct 28, 2026, 13:05N. Mariana S. Vasquez: Antiplatelets vs Anticoagulants – Key Clinical Differences
-
Oct 28, 2026, 12:45Panithaya Chareonthaitawee: A Podcast Walk Through Anticoagulation
-
Oct 28, 2026, 11:55Natalia C. Badillo: Anticoagulation in AF – A Decision Beyond the Score
-
Oct 28, 2026, 08:40Simon Fletcher: The Hidden Burden of Non-Severe Haemophilia
-
Oct 28, 2026, 08:08Paul Agwu: A Low Platelet Count Is Not a Diagnosis – It Is a Clue
-
Oct 28, 2026, 07:54Ifeanyichukwu Ifechidere: When Normal Results Don’t Explain the Bleeding
-
Oct 28, 2026, 06:06Thirunavukkarasu Angappan: Anti-TFPI Antibodies and an Antithrombin-Lowering Drug